Taurolidine/Citrate Lock Therapy for Primary Prevention of Catheter-Related Infections in Cancer Patients: Results of a Prospective, Randomized, Phase IV Trial (ATAPAC).
Fiche publication
Date publication
mai 2017
Journal
Oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr GOETZ Christophe, Dr LONGO Raffaele, Dr QUETIN Philippe
Tous les auteurs :
Longo R, Llorens M, Goetz C, Platini C, Eid N, Sellies J, Ouamara N, Quétin P
Lien Pubmed
Résumé
Totally implantable venous access port (TIVAP)-related infections (RIs) remain a serious health problem in cancer patients receiving an intravenous (i.v.) therapy.
Mots clés
Catheter, Infection, Taurolidine, Totally implantable venous access port
Référence
Oncology. 2017 May;: